Potential applications of violacein: A microbial pigment

Medicinal Chemistry Research

Volumn 21, Issue 7, 2012, Pages 1524-1532

  Durán, Marcela ^a,b   Ponezi, Alexandre N ^a   Faljoni Alario, Adelaide ^b   Teixeira, Maria F S ^c   Justo, Giselle Z ^d   Durán, Nelson ^a,b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSIDADE FEDERAL DO ABC   (Brazil)

^c FEDERAL UNIVERSITY OF AMAZONAS   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chromobacterium violaceum; Cosmetics; Textile; Therapy; Violacein

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIMALARIAL AGENT; ANTIMYCOBACTERIAL AGENT; ANTINEOPLASTIC AGENT; ANTINOCICEPTIVE AGENT; ANTIOXIDANT; ANTIPARASITIC AGENT; ANTIPROTOZOAL AGENT; ANTIPYRETIC AGENT; ANTITRYPANOSOMAL AGENT; ANTIULCER AGENT; ANTIVIRUS AGENT; BETA CYCLODEXTRIN; CASPASE 8; CIMETIDINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; INDOMETACIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MORPHINE; NANOPARTICLE; PHOTOSENSITIZING AGENT; PIGMENT; PYRAZINAMIDE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; VIOLACEIN;

ADENOVIRUS 5; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTINOCICEPTION; ANTIOXIDANT ACTIVITY; ANTIPROTOZOAL ACTIVITY; ANTIPYRETIC ACTIVITY; ANTIULCER ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; BACILLUS MEGATERIUM; BACILLUS SUBTILIS; BACTERIAL GROWTH; BIOLOGICAL ACTIVITY; CHAGAS DISEASE; CHROMOBACTERIUM VIOLACEUM; CLOSTRIDIUM PERFRINGENS; COLON CANCER; CYTOTOXICITY; DRUG EFFICACY; EHRLICH ASCITES TUMOR; ENCAPSULATION; ESCHERICHIA COLI; FUNGUS; GROWTH INHIBITION; HEPATITIS A VIRUS; HERPES SIMPLEX VIRUS; IMMUNOMODULATION; LEISHMANIA; LEUKEMIA; LUNG NON SMALL CELL CANCER; MALARIA FALCIPARUM; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OCHROMONAS; PHOTODYNAMICS; PHOTOSENSITIVITY; PLASMODIUM CHABAUDI; PLASMODIUM CHABAUDI INFECTION; PLASMODIUM FALCIPARUM; PROTOZOON; PSEUDOMONAS AERUGINOSA; REVIEW; ROSELLINIA NECATRIX; SALMONELLA ENTERICA; SINGLE DRUG DOSE; SPUMELLA; STAPHYLOCOCCUS AUREUS; STOMACH ULCER; TRYPANOSOMA CRUZI;

EID: 84861905596     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-011-9654-9     Document Type: Review

References (73)

1. Ahmetagic A, Pemberton JM (2010) Stable high level expression of the violacein indolocarbazole anti-tumour gene cluster and the Streptomyces lividans amy A gene in E. coli K12. Plasmid 63:79-85
2. Alves OL, Gimenez IF, De Azevedo MMM, Durán N, Melo OS (2005) Pharmacological use of cyclodextrine-Au-Thiol-derivative/ hydrophobic compound nanoparticles as antitumoral, antibacterial, antiviral and/or antiparasites, its obtention process and formulation. Brazilian Patent PIBr 0502657-1
3. Andrighetti-Frohner CR, Antonio RV, Creczynski-Pasa TB, Barandi CRM, Simões CMO (2003) Cytotoxicity and potential antiviral evaluation of violacein produced by Chromobacterium violaceum. Mem Inst Oswaldo Cruz 98:834-848
4. Antonisamy P, Ignacimuthu S (2010) Immunomodulatory, analgesic and antipyretic effects of violacein isolated from Chromobacterium violaceum. Phytomedicine 17:300-304
5. Antonisamy P, Kannan P, Ignacimuthu S (2009) Anti-diarrhoeal and ulcer-protective effects of violacein isolated from Chromobacterium violaceum in Wistar rats. Fundam Clin Pharmacol 23: 483-490
6. Aoki S, Nomura T (1998) Violacein-containing natural bactericides, their manufacture, and cosmetics containing them. Jpn Kokai Tokkyo Koho JP 10139612
7. Baek SH, Kang HS, Jang IH, Lee JS, Kim SY, Baek JH, Kang JG, Ahn JM (2007) Insecticide and fungicide containing violacein, and their preparation method. Repub Korean Kongkae Taeho Kongbo KR 2007088150 A
8. Bromberg N, Dreyfuss JL, Regatieri CV, Palladino MV, Durán N, Nader HB, Haun M, Justo GZ (2010) Growth inhibition and proapoptotic activity of violacein in Ehrlich ascites tumor. Chem Biol Interact. doi:10.1016/j.cbi.2010. 04.016
9. Cao W, Chen W, Sun S, Guo P, Song J, Tian C, Cao W, Chen W, Sun S, Guo P, Song J, Tian C (2007) Investigating the antioxidant mechanism of violacein by density functional theory method. Investigating the antioxidant mechanism of violacein by density functional theory method. J Mol Struct Theochem 817:1-4
10. Costa FTM, Justo GZ, Durán N, Nogueira PA, Lopes SCP (2005) The use of violacein in its free and encapsulated form in polymeric systems against malaria. Brazilian Patent PIBr 056399-0
11. De Azevedo MBM, Alderete J, Lino ACS, Loh W, Faljoni-Alario A, Durán N (2000a) Violacein/cyclodextrin inclusion complex by diffusion coefficient and circular dichroism measurements. J Inclusion Phenom Mol Recognit Chem 37:67-74
12. De Azevedo MBM, Alderete J, Rodriguez JA, De Souza AO, Faljoni-Alario A, Durán N (2000b) Biological activities of new antitumoral of indole derivatives in a inclusion complex with cyclodextrin. J Inclusion Phenom Mol Recognit Chem 37: 93-101
13. De Azevedo MBM, Justo GZ, Rettori D, Rodriguez JA, Haun M, Durán N (2000c) Antioxidant activity of an inclusion complex of violacein and β-cyclodextrin. Proc Intern Symp Control Rel Bioact Mater 27:506-507
14. De Azevedo MBM, Melo PS, Almeida ABA, Souza-Brito ARM, Haun M, Durán N (2000d) Antiulcerogenic activity of violacein/ beta-cyclodextrin inclusion complexes and violacein. Proc Intern Symp Control Rel Bioact Mater 27:508-509
15. De Carvalho DD, Costa FTM, Duran N, Haun M (2006) Cytotoxic activity of violacein in human colon cancer cells. Toxicol In Vitro 20:1514-1521
16. De Moss RD (1967) Violacein. Antibiotics 2:77-81
17. De Moss RD, Happel ME (1959) Nutritional requirements of Chromobacterium violaceum. J Bacteriol 77:137-141
18. De Souza AO, Aily DCG, Sato DN, Durán N (1999) In vitro violacein activity against Mycobacterium tuberculosis H37RA. Rev Inst Adolfo Lutz 58:59-62
19. Durán N, De Azevedo MMM (2004) Compound incorporated in a polymeric nanoparticle with pharmaceutical or a cosmetic, its preparation process and cosmetic or pharmaceutical formulations. Brazilian Patent PIBr 0404306-5
20. Durán N, De Souza AO (2001) Process of violacein application as antimycobacterial compound. Brazilian Patent PIBr 0101346-7
21. Durán N, Faljoni-Alario A (1980) Bacterial chemistry-I. Studies of a potential phototherapeutic substance from Chromobacterium violaceum. An Acad Bras Cienc 52:297-302
22. Durán N, Haun M (1991) Trypanocide. State of art. Mem Inst Oswaldo Cruz Suppl I 86:29-30
23. Durán N, Haun M (1997) Production, obtention and purification process and antitumoral activity of 3-[1,2-dihydro-5-(5-hydroxy-1H-indol-3-yl)- 2-oxo-3H-pyrrol-3-ylidene]-1,3-dihydro-2H-indol-2-one. Brazilian Patent PIBr 9702918
24. Durán N, Menck CFM (2001) Chromobacterium violaceum: A Review of pharmacological and industrial perspectives. Crit Rev Microbiol 27:201-222
25. Durán N, Justo GZ, Melo PS, De Azevedo MBM, Souza-Brito ARM, Almeida ABA, Haun M (2003) Evaluation of the antiulcerogenic activity of violacein and its modulation by the inclusion complexation with beta-cyclodextrin. Can J Physiol Pharmacol 81:387-396
26. Durán N, Erazo S, Campos V (1983) Bacterial Chemistry-II. Antimicrobial photoproduct from pigment of Chromobacterium violaceum. An Acad Bras Cienc 55:231-234
27. Durán N, Campos V, Riveros R, Joyas A, Pereira MF, Haun M (1989) Bacterial Chemistry-III. Preliminary studies on trypanosomal activities of Chromobacterium violaceum products. An Acad Bras Cienc 61:31-36
28. Durán N, De Azevedo MBM, Alderete J (1998) Formulation process of cyclodextrin/violacein for using as antibacterial, antitumoral, antiviral and trypanocide. Brazilian Patent PIBr 9801307
29. Durán N, Justo GZ, Melo PS, Martins D Jr, Cordi L (2007) Violacein: properties and biological activities. Biotechnol Appl Biochem 48:127-133
30. Ferreira CV, Bos CL, Versreeg HH, Justo GZ, Durán N, Peppelenbosch MP (2004) Molecular mechanism of violaceinmediated human leukemia cell death. Blood 104:1459-1464
31. Gimenez IF, Anazetti MC, Melo PS, Haun M, De Azevedo MMM, Durán N, Alves OL (2005) Cytotoxicity on V79 and HL60 cell lines by thiolated-beta- cyclodextrin-Au/violacein nanoparticles. J Biomed Nanotechnol 1:352-358
32. Haun M, Pereira MF, Hoffman ME, Riveros R, Joyas A, Campos V, Durán N (1992) Bacterial Chemistry-VI: Biological activities and cyto-toxicity of 1, 3-dihydro-2H-Indol-2-one derivatives. Biol Res 25:21-25
33. Kato H, Hata T, Shirata A, Tsukamoto T (1999) Improvement of lightfastness of fibers or fiber products dyed with violacein or deoxyviolacein bluish purple dyes by treating the dyed fibers with thiourea. Jpn Kokai Tokkyo Koho JP 11152687 A
34. Kidder GW, Stuart CA (1939) Growth studies on ciliates. I. The role of bacteria in the growth and reproduction of Colpoda. Physiol Zoo 12:329-340
35. Kodach LL, Bos CL, Durán N, Peppelenbosh MP, Ferreira CV, Hardwick JCH (2006) Inhibition of Akt-mediated signal transduction in human colorectal cancer cells by violacein abrogates 5-fluorouracil chemoresistance. Carcinogenesis 27:508-516
36. Konzen M, De Marco D, Cordova CAS, Vieira TO, Antonio RV, Creczynski-Pasa TB (2006) Antioxidant properties of violacein: Possible relation on its biological function. Bioorg Med Chem 14:8307-8313
37. Laatsch H, Thomson RH (1984) Spectroscopic properties of violacein and related compound: crystal structure of tetramethylviolacein. J Chem Soc Perkin Trans II 1331-1339
38. Leon LL, Miranda CC, De Souza AO, Durán N (2001) Antileishmanial activity of the violacein extracted from Chromobacterium violaceum. J Antimicrobial Chemother 48:449-450
39. Lichstein HC, Van De Sand VF (1945) Violacein an antibiotic pigment produced by Chromobacterium violaceum. J Infect Dis 76:47-51
40. Lopes SCP, Blanco YC, Justo GZ, Nogueira PA, Rodrigues FLS, Goelnitz U, Wunderlich G, Facchini G, Brocchi M, Durán N, Costa FTM (2009) Violacein extracted from Chromobacterium violaceum inhibits Plasmodium growth in vitro and in vivo. Antimocrob Agents Chemother 53:2149-2152
41. Lu Y, Wang L, Xue Y, Zhang C, Xing XH, Lou K, Zhang Z, Li Y, Zhang G, Bi J, Su Z (2009) Production of violet pigment by a newly isolated psychrotrophic bacterium from a glacier in Xinjiang, China. Biochem Eng J 43:135-141
42. Martins D, Costa FTM, Brocchi M, Durán N (2010a) Evaluation of the antibacterial activity of poly-(D,L-lactide-co-glycolide) nanoparticles containing violacein. J Nanopart Res (submitted)
43. Martins D, Frungillo L, Anazzetti MC, Melo PS, Durán N (2010b) Antitumoral activity of L-ascorbic acid-poly-D,L-(lactide-co-glycolide) nanoparticles containing violacein. Intern J Nanomed 5:77-85
44. Matz C, Deines P, Boenigk J, Arndt H, Eberl L, Kjellberg S, Jurgens K (2004) Impact of violacein-producing bacteria on survival and feeding of bacterivorous nanoflagellates. Appl Environ Microbiol 70:1593-1599
45. May G, Brummer B, Ott H (1991) Purification of the antiviral compound violacein from cultures of Chromobacterium. Ger Offen DE 3935066
46. Meiring U, Lanzendoerfer G, Riedel H, Kallmayer V, Viala S, Mocigemba N, Schaefer J (2007) Cosmetic preparations containing violacein as dye. Ger Offen DE 102005051869:A1
47. Melo PS, Maria SS, Vidal BC, Haun M, Duran N (2000) Violacein cytotoxicity and induction of apoptosis in V79 cells. In Vitro Cell Dev Biol Anim 36:539-543
48. Melo PS, Justo GZ, De Azevedo MBM, Durán N, Haun M (2003) Violacein and its beta-cyclodextrin complexes induce apoptosis and differentiation in HL60 cells. Toxicology 186:217-225
49. Melo PS, De Azevedo MMM, Frungillo L, Anazetti MC, Marcato PD, Durán N (2009) Nanocytotoxicity: Violacein and violaceinloaded poly (D,L-lactide-co-glycolide) nanoparticles acting on human leukemic cells. J Biomed Nanotechnol 5:192-201
50. Mendes AS, De Carvalho JE, Duarte MCT, DuránN, Bruns RE (2001a) Optimized production process of violacein and deoxyviolacein by Chromobacterium violaceum by factorial design and response surface methodology. Brazilian Patent PIBr 0100199-0
51. Mendes AS, De Carvalho JE, Duarte MCT, Durán N, Bruns RE (2001b) Factorial design and response surface optimization of crude violacein for Chromobacterium violaceum production. Biotechnol Lett 23:1963-1969
52. Naito S, Shiga I, Yamaguchi N (1986) Antimicrobial activity of violet pigment produced by Janthinobacterium lividum isolated from Yudemen. Nippon Shokuhin Kogyo Gakkaishi 33:759-763
53. Nakamura Y, Sawada T, Morita Y, Tamiya E (2002) Isolation of a psychrotrophic bacterium from the organic residue of a water tank keeping rainbow trout and antibacterial effect of violet pigment produced from the strain. Biochem Eng J 12:79-86
54. Nakamura Y, Asada C, Sawada T (2003) Production of antibacterial violet pigment by psychrotropic bacterium RT102 strain. Biotechnol Bioprocess Eng 8:37-40
55. Nomura T (1994) Natural dye violacein manufacture with Chromobacterium and Janthiobacterium. Jpn Kokai Tokkyo Koho JP 06253864 A
56. Pantanella F, Berlutti F, Passariello C, Sarli S, Morea C, Schippa S (2007) Violacein and biofilm production in Janthinobacterium lividum. J Appl Microbiol 102:992-999
57. Philip DS, Sarovich DS, Pemberton JM (2008) pPSY: a vector for the stable cloning and expression of streptomycete single gene phenotypes in Escherichia coli. Plasmid 60:53-58
58. Philip DS, Sarovich DS, Pemberton JM (2009) Complete sequence and analysis of the stability functions of pPSX, a vector that allows stable cloning and expression of Streptomycete genes in Escherichia coli K12. Plasmid 62:39-43
59. Rettori D, Durán N (1997) Stationary tray bioreactor for the bacterial metabolite production. Brazilian Patent PIBr 9702986-6
60. Rettori D, Rodriguez RA, Durán N (1998) Chromobacterium violaceum under oxidative stress. Rev Farm Bioquim Univ São Paulo 34(Suppl. 1):169-169
61. Riveros R, Haun M, Durán N (1989) Bacterial Chemistry-V: Effect of growth conditions on production of violacein by Chromobacterium violaceum BB-78 strain. Brazilian J Med Biol Res 22: 569-577
62. Saraiva VS, Marshall J-C, Cools-Lartigue J, Burnier MN Jr (2004) Cytotoxic effects of violacein in human uveal melanoma cell lines. Melanoma Res 14:421-424
63. Sarovich DS, Pemberton JM (2007) pPSX: a novel vector for the cloning and heterologous expression of antitumor antibiotic gene clusters. Plasmid 57:306-313
64. ShirataA, Tsukamoto T, Yasui H, KatoH, Hayasaka S, KojimaA(1997) Production of bluish-purple pigments by Janthinobacterium lividum isolated from the raw silk and dyeing with them. Nippon Sanshigaku Zasshi 66:377-385
65. Shirata A, Tsukamoto T, Kato H, Hata T, Yasui T, Kojima A (1998) Blue purple pigment manufacture with microorganism and applications of the pigment. Jpn Kokai Tokkyo Koho JP 10113169 A
66. Shirata A, Tsukamoto T, Yasui H, Hata T, Hayasaka S, Kojima A, Kato H (2000) Isolation of bacteria producing bluish-purple pigment and use for dyeing. Japan Agric Res Quart 34:131-140
67. Sousa AO, Egito LCM, Medeiros SRB, Agnez-Lima LF (2005) Study on genotoxicity of violacein. Genet Mol Biol 28(Supl):183
68. Takii T, Hamasaki S, Hirano K, Abe C, Onozaki K (2005) Simple fibroblast-based assay to test the pyrazinamide susceptibility of Mycobacterium tuberculosis. Antimicrob Agents Chemother 49:804-807
69. Tan TL, Montforts FP, Meyer D (2002) Microbiological method for the biosynthesis of natural blue-violet colorants violacein and desoxyviolacein. PCT Int. Appl. WO 2002050299 A2
70. Tobie WC (1934) The pigment of Bacillus violaceus I. The production, extraction, and purification of violacein. J Bacteriol 29:223-227
71. Wang H, Jiang P, Lu Y, Ruan Z, Jiang R, Xing XH, Lou K, Wei D (2009) Optimization of culture conditions for violacein production by a new strain of Duganella sp. B2. Biochem Eng J 44:119-124
72. Yada S, Wang Y, Zou Y, Nagasaki K, Hosokawa K, Osaka I, Arakawa R, Enomoto K (2008) Isolation and characterization of two groups of novel marine bacteria producing violacein. Marine Biotechnol 10:128-132
73. Yang LH, Xiong H, Lee OO, Qi SH, Qian PY (2007) Effect of agitation on violacein production in Pseudoalteromonas luteoviolacea isolated from a marine sponge. Lett Appl Microbiol 44:625-630